CD8A and neoplasm: Success with anti-PD-L1 has also been found with the loading of metformin, a drug typically used to treat high blood glucose, into macrophage-derived EVs which then degrades the collagen of the tumor and renders it more likely to infiltration by CD8+ T cells [31].